China’s top securities regulator and Shanghai’s stock exchange announced on June 17, 2026, that loss-making artificial intelligence companies and deep-tech startups can now access China’s public equity markets without turning a profit — a structural shift timed explicitly against Wall Street’s simultaneous wave of high-profile technology listings. The announcement, made at the annual Lujiazui Forum in Shanghai, extends the Shanghai Stock Exchange STAR Market’s "fifth listing standard" to AI large-model developers, quantum technology companies, brain-computer interface makers, and seven other frontier sectors, with rules taking effect immediately. The move is not merely a capital markets reform: because China’s fifth listing standard requires government approval of a company’s core technology as an eligibility criterion, Beijing has embedded its own industrial policy gatekeeping directly into the public equity system — making the stock market a tool for selecting which technologies receive state-endorsed funding, not just which ones attract private capital.
Why China Is Moving Now
The Lujiazui Forum announcement arrived the week that SpaceX completed the largest initial public offering in history on the Nasdaq, and as OpenAI and Anthropic were advancing their own Wall Street listings. The overlap was not coincidental. China Securities Regulatory Commission Chairman Wu Qing said at the forum that "major capital markets around the world are accelerating reforms to better adapt to the needs of innovation and gain leading positions," framing the STAR Market expansion as a direct competitive response to Western market structures that have allowed loss-making frontier tech companies to raise public capital for decades.
Chinese AI developers face a structural fundraising disadvantage that this expansion is designed to close. Zhipu AI and MiniMax both went public on Hong Kong’s exchange in January 2026 — raising a combined $1.1 billion before OpenAI or Anthropic filed — but both remain deeply loss-making, and Hong Kong’s market is smaller and more volatile than the A-share domestic market. Zhipu’s shares have risen more than tenfold from their IPO price; MiniMax has tripled. The new rules give companies like these a path to Shanghai’s larger domestic investor base without the profitability threshold that has historically blocked them from China’s main exchanges.
At the same forum, however, Wu simultaneously warned that regulators would "strictly investigate and punish" illicit activities including market manipulation and the use of hot technology themes to hype stock prices — signaling that Beijing is threading a narrow line between opening the IPO door and preventing speculative excess in an AI equity rally that has already produced extreme price swings in Chinese tech stocks.
How the Fifth Listing Standard Actually Works
The STAR Market, officially the Shanghai Stock Exchange Science and Technology Innovation Board, was established in July 2019 as China’s answer to Nasdaq — a dedicated board for technology and innovation companies with more permissive listing requirements than China’s traditional exchanges. It operates five listing "standards" with progressively relaxed financial thresholds. Standard I requires demonstrated profitability. Standards II through V progressively relax that requirement, with Standard V — the "fifth listing standard" — eliminating it entirely.
The fifth standard uses a "market value plus R&D" evaluation framework instead of profitability metrics. For AI large-model companies specifically, the Shanghai Stock Exchange confirmed the following requirements: a minimum anticipated market capitalization of approximately 4 billion yuan (roughly $591 million); at least one large language model product launched and operating at scale; "clear commercialization arrangements"; sustained high-intensity R&D investment and computing power commitments; and — critically — approval by central government authorities of the company’s core business or products. That last requirement is the mechanism through which state industrial policy becomes IPO policy: a company whose technology Beijing has not endorsed cannot meet the eligibility test, regardless of its market cap or technical capability.
The standard does not require revenue, does not require positive cash flow, and does not require a path to profitability within any specified timeframe. Companies that list under it receive a "U" designation on their stock symbol — a visible marker that alerts investors to their pre-profit status — and are placed in a dedicated "Science and Technology Innovation Growth Tier" created by the CSRC in June 2025. To graduate from that tier, a company must achieve either two consecutive years of positive net profit with cumulative earnings above 50 million yuan, or a single year of profit with operating revenue above 100 million yuan.
The fifth standard was originally available when the STAR Market launched in 2019, was suspended by regulators in 2023 after concerns about investor protection, and was formally revived at the 2025 Lujiazui Forum as part of a broader "1+6" reform package. The June 2026 announcement is its most significant sector expansion: prior to this week, the standard had been applied primarily to biomedical companies, AI chipmakers, and commercial aerospace firms. It now formally covers AI large-model developers, quantum technology, 6G communications, brain-computer interfaces, nuclear fusion, hydrogen energy, robotics, and biomedical engineering — nearly the complete list of sectors subject to escalating U.S. technology export controls targeting China.
State Approval as Listing Criterion: Industrial Policy Through the Stock Exchange
The CSRC’s own description of how the fifth listing standard functions makes the state-selection mechanism explicit. The Shanghai Stock Exchange’s official documentation states that eligible companies’ "main business or products are approved by the state" and must demonstrate "large market space" and "phased results" in R&D. Government approval is not a preference or a tiebreaker — it is a threshold criterion.
This design means the STAR Market’s fifth standard is not a capital markets mechanism that serves any eligible innovative company. It is a mechanism that serves companies whose technology Beijing has decided to fund. Edward Au, Southern Region managing partner at Deloitte China, described the selection logic directly: "If a company has innovations that can help the country overcome tech chokepoints, it will likely get a greenlight." The sectors newly added in the June 2026 expansion — quantum, 6G, brain-computer interfaces, embodied AI — are precisely the technologies that Washington’s Bureau of Industry and Security and the Committee on Foreign Investment in the United States have identified as dual-use national security priorities subject to export controls.
This creates a structural dynamic that policymakers in Washington, Brussels, and Tokyo must now factor into their technology-restriction strategies: China has created a publicly funded, publicly traded industrial policy engine that channels domestic retail investor capital into the same frontier technologies that Western export controls are trying to deny China access to. By making equity market access contingent on state approval, Beijing can direct public capital flows toward strategic priorities with a precision that private venture funding cannot replicate.
Who Is in Line: Companies and Their Track Records
CSRC Chairman Wu Qing confirmed that homegrown companies including memory-chip developer ChangXin Memory Technologies are among those lining up for domestic listings. Unitree Robotics — China’s most prominent humanoid robot developer and the first "embodied AI" company to clear the STAR Market’s listing committee review, which it did on June 1, 2026 — is completing the registration and pricing process ahead of its initial trading.
Zhipu AI, which debuted on the Hong Kong exchange in January 2026 at a $558 million raise and has since seen its shares rise more than tenfold, has been identified as a candidate to seek a concurrent or secondary A-share listing now that the fifth standard explicitly covers large-model developers. The company is on the U.S. Commerce Department’s Entity List following a January 2025 designation for alleged ties to China’s military. MiniMax, whose Hong Kong shares have tripled since its January 2026 debut, is similarly positioned as a potential beneficiary of the expanded pathway.
The track record of prior fifth-standard listings warrants scrutiny. Of the 54 unprofitable companies that listed under the fifth standard before it was suspended in 2023, 32 remained unprofitable as of mid-2025, according to an analysis by Liang Ding, an independent economist based in Shanghai. Most underperformed the top segment of the STAR Market. "There are good reasons to be cautious," Liang said. Andrew Collier, managing director of Orient Capital Research, offered a sharper warning: a government-backed listing "is going to convince people that this is a surefire winner because the government’s behind it. In the near term, it could provide some additional juice to the market. But when these companies fail to deliver the results that people expect, that juice will evaporate."
Not every outcome has been negative. Cambricon, a Beijing-based AI chipmaker that listed under the fifth standard in 2020, saw its shares rise approximately twenty-fold before a partial correction, and reported its first quarterly profit in late 2025 as China’s domestic AI chip demand surged. Moore Threads, a GPU maker that authorities approved for listing despite cumulative losses of 5.2 billion yuan ($730 million) since 2022, aims to raise 8 billion yuan and represents the kind of strategically critical but deeply unprofitable company the expanded framework is designed to serve.
What the STAR Market Expansion Cannot Do
The fifth listing standard creates a public equity path, but it does not solve the structural constraint that has most limited China’s frontier AI and quantum development: access to advanced semiconductors. The same U.S. export controls that restrict sales of Nvidia’s most capable AI accelerators to Chinese buyers are not affected by whether a Chinese AI company is publicly or privately held. A Zhipu AI or a quantum technology firm listed on the STAR Market is still subject to the same chip-supply limitations as an unlisted one.
The capital raised through the fifth standard pathway can fund domestic chip procurement, headcount, and compute infrastructure — and, critically, can help Chinese companies stockpile U.S.-accessible hardware before any tightening of controls closes that window further. But it cannot substitute for the semiconductor ecosystem that American export policy is deliberately withholding. China’s STAR Market expansion and Washington’s export control regime are operating on parallel tracks, each reinforcing the other’s urgency.
CSRC’s broader reform package also includes the launch of active exchange-traded funds on Shanghai and Shenzhen exchanges, reforms to the ChiNext board targeting new consumption and modern services sectors, support for qualified Hong Kong-listed companies to seek secondary A-share listings, and exploration of a renminbi foreign exchange futures pilot. Taken together, the package represents Beijing’s most systematic effort to rebuild its capital markets as globally competitive instruments for the AI era — not just domestically, but as an alternative destination for international investors who Wu said are paying growing attention to Chinese assets for their "safety, resilience and innovation value."
Frequently Asked Questions
What exactly does China’s fifth listing standard require for AI model companies?
For AI large-model developers, the Shanghai Stock Exchange’s framework requires a minimum anticipated market capitalization of approximately 4 billion yuan (about $591 million), at least one large language model product launched and operating at scale, clear commercialization arrangements, sustained R&D and computing investment, and — the requirement that distinguishes it from most Western listing standards — explicit approval by Chinese central government authorities of the company’s core business or products. Revenue and profit are not required. Companies that list under these criteria receive a "U" symbol designation and are placed in a dedicated growth tier until they meet profitability thresholds.
Why is the fifth listing standard’s state-approval requirement significant for investors and policymakers outside China?
The state-approval criterion means the STAR Market’s pre-profit IPO access is not available to all innovative companies — only to those whose technology Beijing has designated as strategically important. This makes the STAR Market a direct implementation tool for China’s industrial policy, directing retail investor capital toward sectors the government has prioritized rather than sectors the market has self-selected. For investors, it means "U"-designated stocks carry both elevated commercial risk (pre-revenue companies in deep-tech with long development timelines) and elevated political risk (companies whose continuation depends in part on maintaining state endorsement). For Western policymakers, it means China now has a mechanism to finance the exact frontier technologies — quantum, 6G, brain-computer interfaces, embodied AI — that U.S. export controls are attempting to restrict.
How has the fifth listing standard performed historically, and what does that track record mean for the current expansion?
Of the 54 companies that went public under the fifth standard before it was suspended in 2023, 32 remained unprofitable as of mid-2025. Most underperformed the top tier of the STAR Market. A handful — notably AI chipmaker Cambricon — produced exceptional returns as China’s domestic AI demand accelerated. The expansion to AI large-model and quantum companies in June 2026 targets sectors with even longer development timelines and larger capital requirements than the biotech companies that constituted most prior fifth-standard listings. The "U" designation system and growth-tier disclosure requirements added in the 2025 reforms are designed to give investors clearer risk signals than the original 2019 framework provided.
What companies are most likely to file under the expanded fifth listing standard first?
Among large-model developers, Zhipu AI (already listed in Hong Kong) and MiniMax (also Hong Kong-listed) are identified as candidates for A-share listings now that the fifth standard covers their sector. Memory-chip developer ChangXin Memory Technologies has been confirmed by CSRC officials as lining up for a domestic listing. Humanoid robotics maker Unitree Robotics is already in the registration and pricing phase following its June 1, 2026 listing committee approval. In each case, the prerequisite is obtaining — or demonstrating existing — central government approval for the company’s core technology, which functions as a regulatory gatekeeping step before the market mechanism applies.
Enjoyed this article? Sign up for our newsletter to receive regular insights and stay connected.